MGI gene sequencing company

Location: Home /  News Center

MGI Helps to Draft First Specifications of Remote Robotic Ultrasound System for COVID-19 Diagnosis

Release date:2021-02-07Writer:MGIViews:200Share

SHENZHEN, China, Feb 7, 2021-- Shenzhen Life Science and Technology University-Industry-Institute Alliance released the industry’s first “Specifications of Remote Robotic Ultrasound Systems for COVID-19 Diagnosis”, (referred to as the Specifications), providing technical references for institutions applying robotic ultrasound diagnosis in COVID-19 diagnosis.


 

The First Specifications of Remote Robotic Ultrasound Systems for COVID-19 Diagnosis


Compared with the traditional ultrasound examination, MGI’s 5G-network-based robot-assisted remote ultrasound system, MGIUS-R3, can be operated by a doctor through the control system up to 1800 kilometers away to ensure the safety for both the patients and examiners.

 

The Specifications was co-drafted by MGI, the 3th Medical Center of the General Hospital of People’s Liberation Army, China, Zhejiang Provincial People’s Hospital, Shenzhen Luohu People’s Hospital, Shenzhen Institute for Drug Control, BGI Group, BGI Genomics and Shenzhen Life Science and Technology University-Industry-Institute Alliance.


MGI’s Remote Ultrasound Robot System, MGIUS-R3

 

MGI’s remote ultrasound robot contributing to the fight against COVID-19 pandemic

 

Since the beginning of the outbreak, MGI’s robotic ultrasound system, nicknamed the remote ultrasound robot, has been supporting the prevention and control of COVID-19 on the frontline in many places. During the COVID-19 pandemic in Wuhan, MGIUS-R3 was delivered to front line hospitals 2,000 kilometers away, helping doctors to conduct remote diagnosis that effectively reduces the risk of COVID-19transmission to medical personnel and saves the lives of patients. MGIUS-R3 has supported the hospitals in Wuhan e.g. Huangpi Cabin Hospital, Leishenshan Hospital (the hospital for critical patients infected by COVID-19) Zhongnan Hospital of Wuhan University, Zhejiang Provincial People’s Hospital, Beijing 301 Hospital and Hainan 301 Hospital by offering patients in remote regions access to diagnosis and healthcare services by medical experts from the hospital thousands of kilometres away.   

 

 

In addition, MGI’s remote ultrasound robot has also attracted the attention of experts and scholars in the fighting against COVID-19. Since the building of Leishenshan Hospital in 2020, a total of four (4) academic papers and two (2) expert consensus documents on MGI’s remote ultrasound robot have been published. Among them, the most influential one “Feasibility of a 5G-Based Robot-Assisted Remote Ultrasound System for Cardiopulmonary Assessment of Patients with Coronavirus Disease 2019” was published on the top journal CHEST, which further proves the application value of remote ultrasound robots in COVID-19.

 

The release of the “Specifications” will provide important guidance for robotic ultrasound diagnosis in the fight against the pandemic. The use of the remote ultrasound system helps distribute high-quality medical resources to aid resource-constrained areas and provide more high-quality services to patients.